![Gregg Peterson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Postes actifs de Gregg Peterson
Sociétés | Poste | Début | Fin |
---|---|---|---|
Bexson Biomedical, Inc.
![]() Bexson Biomedical, Inc. BiotechnologyHealth Technology Bexson Biomedical, Inc. is a research stage company based in Santa Barbara, CA. The company is focused on developing BB106, a ketamine therapy for pain management and mental health disorders. The company is also applying their proprietary delivery platform to several psychedelic and non-psychedelic compounds to reduce suffering caused by pain, addiction, and mental health conditions. The company was founded by Jeffrey Becker and Gregg Peterson has been the CEO of the company since 2019. | Directeur/Membre du Conseil | 01/02/2019 | - |
Directeur Général | 01/02/2019 | - |
Historique de carrière de Gregg Peterson
Statistiques
Internationale
Etats-Unis | 2 |
Opérationnelle
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Sectorielle
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Bexson Biomedical, Inc.
![]() Bexson Biomedical, Inc. BiotechnologyHealth Technology Bexson Biomedical, Inc. is a research stage company based in Santa Barbara, CA. The company is focused on developing BB106, a ketamine therapy for pain management and mental health disorders. The company is also applying their proprietary delivery platform to several psychedelic and non-psychedelic compounds to reduce suffering caused by pain, addiction, and mental health conditions. The company was founded by Jeffrey Becker and Gregg Peterson has been the CEO of the company since 2019. | Health Technology |
- Bourse
- Insiders
- Gregg Peterson
- Expérience